![Wolf-Dieter Busse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolf-Dieter Busse
Keine laufenden Positionen mehr
Profil
Wolf-Dieter Busse is the founder of Aerovance, Inc. (2004) and ACT Biotech, Inc. (2008).
He held the title of Chief Executive Officer at both companies.
Dr. Busse is also the founder of Molecular Diagnostics & Therapeutics, Inc. Dr. Busse received an undergraduate degree from RWTH Aachen University.
Ehemalige bekannte Positionen von Wolf-Dieter Busse
| Unternehmen | Position | Ende |
|---|---|---|
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital invests in companies located in the United States and Europe. The firm targets companies operating in the fields of healthcare and biotechnology. It participates in early and later stage capital requirements. | Corporate Officer/Principal | 30.06.2008 |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Gründer | - |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Corporate Officer/Principal | - |
Molecular Diagnostics & Therapeutics, Inc.
 Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes nuclear medicines | Gründer | - |
CHI AB | Direktor/Vorstandsmitglied | - |
Ausbildung von Wolf-Dieter Busse
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Molecular Diagnostics & Therapeutics, Inc.
Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes nuclear medicines | Health Technology |
Aerovance, Inc.
Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital invests in companies located in the United States and Europe. The firm targets companies operating in the fields of healthcare and biotechnology. It participates in early and later stage capital requirements. | Finance |
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Health Technology |
CHI AB |
Wählen Sie MarketScreener 
